Transdifferentiation of Neuroendocrine Cells
Camille Sergeant(Hospices Civils de Lyon), Chiara Villa(Centre National de la Recherche Scientifique), Gérald Raverot(Université Claude Bernard Lyon 1), Delphine Leclercq(Sorbonne Université), Jacqueline Trouillas, Adrian Daly(Centre Hospitalier Universitaire de Liège), Christel Jublanc(Sorbonne Université), Anne-Laure Boch(Sorbonne Université), Franck Bielle(Centre National de la Recherche Scientifique)
Cited by 22
Related Papers
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study
|The Journal of Clinical Endocrinology & Metabolism|2010|374
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
|Endocrine Related Cancer|2017|357
Gigantism and Acromegaly Due to Xq26 Microduplications and <i>GPR101</i> Mutation
|New England Journal of Medicine|2014|340
Pangenomic Classification of Pituitary Neuroendocrine Tumors
|Cancer Cell|2019|335
BRAF Inhibition in <i>BRAF</i> <sup>V600</sup> -Mutant Gliomas: Results From the VE-BASKET Study
|Journal of Clinical Oncology|2018|330